Cargando…

Time to consider an Asian guideline for management of dyslipidemia?

Detalles Bibliográficos
Autores principales:	Yokote, Koutaro, Saito, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014938/ https://www.ncbi.nlm.nih.gov/pubmed/24843566 http://dx.doi.org/10.1111/j.2040-1124.2012.00206.x

Ejemplares similares

Updates on dyslipidemia in patients with diabetes
por: Ide, Shintaro, et al.
Publicado: (2023)

Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia
por: Yamashita, Shizuya, et al.
Publicado: (2020)

2018 Guidelines for the management of dyslipidemia
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2018 Guidelines for the Management of Dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2018 Guidelines for the management of dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2022 Saudi Guidelines for the Management of Dyslipidemia
por: AlRahimi, Jamilah, et al.
Publicado: (2023)

2015 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines - Executive Summary: Dyslipidemia Guidelines 2015
por: Guerrero, Adriel E.
Publicado: (2016)

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China()
por: Hu, Da-Yi
Publicado: (2016)

Overview of guidelines for the management of dyslipidemia: EU perspectives
por: Giner-Galvañ, Vicente, et al.
Publicado: (2016)

2016 Chinese guidelines for the management of dyslipidemia in adults
Publicado: (2018)

Comparison of Current International Guidelines for the Management of Dyslipidemia
por: Aygun, Sevda, et al.
Publicado: (2022)

Obesity and Dyslipidemia in South Asians
por: Misra, Anoop, et al.
Publicado: (2013)

The good physician and the great physician: why a physician should consider the ESMO guidelines on the management of cancer cachexia?
por: Laviano, A.
Publicado: (2022)

One more step toward an Asian hypertension guideline
por: Wang, Ji‐Guang
Publicado: (2021)

Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action
por: Athyros, Vasilios Gabriel, et al.
Publicado: (2016)

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
por: Harada-Shiba, Mariko, et al.
Publicado: (2018)

Editorial: Secondary Dyslipidemias
por: Elisaf, Moses, et al.
Publicado: (2011)

Dyslipidemia and Breast Cancer
por: Aggarwal, Neelam, et al.
Publicado: (2018)

Endothelial stiffening in dyslipidemia
por: Le Master, Elizabeth, et al.
Publicado: (2019)

Immunosuppression in Renal Transplantation and Dyslipidemia, Which Factors Should Be Considered?
por: De Giorgi, Alfredo, et al.
Publicado: (2013)

2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)
Publicado: (2016)

Executive Summary of the 2020 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines
por: Gonzalez-Santos, Lourdes Ella, et al.
Publicado: (2021)

Updated guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists
por: Babadagli, Hazal E., et al.
Publicado: (2023)

The Draupadi of dyslipidemia: Familial hypercholesterolemia
por: Kalra, Sanjay, et al.
Publicado: (2016)

Management of Dyslipidemia in Secondary Prevention of Cardiovascular Disease: The Gap between Theory and Practice
por: Santangelo, Gloria, et al.
Publicado: (2022)

Management of the malnourished patient: it’s now time to revise the guidelines
por: Kohn, Michael R., et al.
Publicado: (2022)

Primary Prophylaxis of Overt Hepatic Encephalopathy: Is It Time to Consider It?
por: Faccioli, Jessica, et al.
Publicado: (2023)

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
por: Saito, Yasushi
Publicado: (2009)

Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management Strategies
por: Du, Zhiyong, et al.
Publicado: (2023)

Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
por: Misra, Sanjana, et al.
Publicado: (2022)

It Is Time to Consider Human Leukocyte Antigen Compatibility in Lung Transplantation
por: Rhee, Chin Kook
Publicado: (2022)

Childhood Immunity and Infections: Time to Consider Endothelial Cells and Platelets
por: Buonsenso, Danilo
Publicado: (2022)

Is obesity an absolute evil? Increase in adipose tissue does not always decrease insulin sensitivity
por: Ishikawa, Ko, et al.
Publicado: (2014)

Human glomerular transcriptome of diabetic kidneys: Can the podocyte cytoskeleton be a therapeutic target?
por: Maezawa, Yoshiro, et al.
Publicado: (2018)

Novel mechanism of increasing cerebral vascular constriction in acute hyperglycemia and diabetes through adenylyl cyclase 5‐generated cyclic adenosine monophosphate
por: Sakamoto, Kenichi, et al.
Publicado: (2019)

Can we catch the second loach employing BACE1 inhibition, even as the first one might be escaping?
por: Ono, Hiraku, et al.
Publicado: (2021)

Considering the healthcare needs of older people with multimorbidity: managing Alice
por: Chew-Graham, Carolyn A., et al.
Publicado: (2016)

Role of Complementary and Alternative Medicine in Controlling Dyslipidemia
por: Qidwai, Waris, et al.
Publicado: (2014)

Diets, Foods and Food Components’ Effect on Dyslipidemia
por: Fogacci, Federica, et al.
Publicado: (2021)

Chagas Disease in HIV-Infected Patients: It’s Time to Consider the Diagnosis
por: Nolan, Melissa S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_di0o22nhs63rdgdjuc2gnk86p0